Braithwaite R, Jelovac A, Kellner CH, Sartorius A, Sienaert P, McLoughlin DM. Ketamine versus ECT for major depression: flawed evidence base. Lancet Psychiatry. 2026 13(3):180-182. Epub 2025 Oct 22.
Dreger M, Uphaus A, Zilles-Wegner D, Sartorius A, Guhra M, Kreisel S. Electroconvulsive therapy in Germany: a nationwide multilevel analysis of determinants, regional patterns, and institutional variation. Eur Arch Psychiatry Clin Neurosci. 2026 Jun 26. [Epub ahead of print]
Gründer G, Mertens L, Jungaberle A, Jungaberle H, Spangemacher M. Compassionate use of psilocybin for treatment-resistant depression in Germany. Lancet Psychiatry. 2026 13(2):91-93. Epub 2025 Sep 18.
Kassar O, Selim A, Insan S, Hassan O, Sartorius A. Efficacy and safety of continuous theta burst stimulation for auditory hallucinations: A GRADE-assessed meta-analysis of randomized sham-controlled trials. Asian J Psychiatr. 2026 116:104822.
Kellner CH, Sartorius A, Espinoza RT. The Evidence Base for Electroconvulsive Therapy (ECT) in Geriatric Depression. Am J Geriatr Psychiatry. 2026 34(1):134-135. Epub 2025 Jul 5.
Knabbe J, Sartorius A. Just a Caffeine-Blocker? Questioning New Proposed Core Mechanisms of ECT. Brain Stimul. 2026 19(3):103108. Epub 2026 Apr 25.
Mertens L, Betzler F, Brand M, Evens R, Jungaberle A, Jungaberle H, Kärtner L, Majic T, Schmitz C, Ströhle A, Scharf D, Spangemacher M, Wolff M, Assadi Z, Bahri S, Becher L, Färber LV, Harder H, Kirchen N, Kulakova E, Kunz LC, Meijer A, Rohrmoser B, Wellek S, Berger M, Koslowski M, Gründer G. Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial. Psychother Psychosom. 2026 May 27. [Epub ahead of print] :1-28.
Mertens L, Koslowski M, Betzler F, Brand M, Evens R, Kärtner L, Jungaberle A, Jungaberle H, Majic T, Schmitz C, Ströhle A, Scharf D, Spangemacher M, Wolff M, Assadi Z, Bahri S, Becher L, Färber LV, Kirchen N, Kulakova E, Kunz L, Meijer A, Rohrmoser B, Wellek S, Berger M, Gründer G. Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial. JAMA Psychiatry. 2026 83(5):448-460. Epub 2026 Mar 18.
Pedraz-Petrozzi B, Wilkening J, Ziegler N, Arns M, Sartorius A, Goya-Maldonado R. Baseline inflammatory profiles in moderate-to-severe depression and differential response to intermittent theta-burst stimulation. Prog Neuropsychopharmacol Biol Psychiatry. 2026 Jun 27. [Epub ahead of print] :111814.
Sartorius A, Zilles-Wegner D. A unified voice for evidence-based psychiatry: a global response to the WHO guidance on ECT. Eur Arch Psychiatry Clin Neurosci. 2026 276(4):1351-1353. Epub 2026 Apr 28.
Spangemacher M, Reinwald J, Karl S, Sartorius A. Rethinking Seizure Termination: A Possible Paradigm Shift in Understanding a Primary Mechanism of ECT. J ECT. 2026 Mar 4. [Epub ahead of print]
Volkmer S, Kubera KM, Fritze S, Brandt G, Akkoc Altinok DC, Daub J, Kukovic J, Böttcher KT, Berhe O, Lin Y, Tost H, Marquand AF, Meyer-Lindenberg A, Schwarz E, Hirjak D. Normative age-related structural brain deviations underlying psychopathology, cognitive impairment and neurological soft signs in schizophrenia spectrum disorders. Transl Psychiatry. 2026 16(1):197. Epub 2026 Mar 20.
Zilles-Wegner D, Sartorius A. Electroconvulsive therapy and the WHO: patients and professionals deserve expertise and facts, not ideology. Nervenarzt. 2026 97(4):397-399. Epub 2025 Aug 25.
Zilles-Wegner D, Wasserman D, Schulze TG, Pogarell O, Miskimen T, Rapaport MH, Summergrad P, Fiorillo A, Arango C, Global Expert Taskforce on ECT Global Expert Taskforce on ECT, Sartorius A. Joint statement by the World Psychiatric Association, the American Psychiatric Association, the European Psychiatric Association, and the Global Expert Task Force on ECT on the portrayal of electroconvulsive therapy in the WHO Guidance on Mental Health Policy and Strategic Action Plans. Lancet Psychiatry. 2026 13(5):441-444. Epub 2026 Mar 31.